Nuvectis Pharma, Inc. (NVCT)
25.00
+0.64
(+2.61%)
USD |
NASDAQ |
Sep 04, 12:20
Nuvectis Pharma Net Income (Annual) : -28.87M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -28.87M |
| December 31, 2024 | -19.00M |
| December 31, 2023 | -22.26M |
| Date | Value |
|---|---|
| December 31, 2022 | -19.08M |
| December 31, 2021 | -12.89M |
| December 31, 2020 | -0.01M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Decoy Therapeutics, Inc. | -12.52M |
| Unicycive Therapeutics, Inc. | -26.56M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |